Janux Historical Financial Ratios

JANX Stock  USD 45.21  1.18  2.54%   
Janux Therapeutics is lately reporting on over 92 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as PTB Ratio of 1.44 or Days Sales Outstanding of 0.0 will help investors to properly organize and evaluate Janux Therapeutics financial condition quickly.
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Janux Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Janux Stock please use our How to Invest in Janux Therapeutics guide.

About Janux Financial Ratios Analysis

Janux TherapeuticsFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Janux Therapeutics investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Janux financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Janux Therapeutics history.

Janux Therapeutics Financial Ratios Chart

At this time, Janux Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Ebt Per Ebit is likely to rise to 1.14 in 2024, despite the fact that Free Cash Flow Yield is likely to grow to (0.11).
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Ev To Sales

The Enterprise Value to Sales ratio, a valuation metric used to compare the value of a company, including debt and excluding cash, to its sales revenue.

Payables Turnover

A liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable.

Capex To Revenue

The ratio of a company's capital expenditures to its total revenue, indicating how much of the revenue is used for acquiring or maintaining physical assets.

Return On Assets

A profitability ratio that indicates the percentage of profit a company earns in relation to its overall resources. It is calculated by dividing net income by total assets.
Most ratios from Janux Therapeutics' fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Janux Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Janux Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
For more information on how to buy Janux Stock please use our How to Invest in Janux Therapeutics guide.At this time, Janux Therapeutics' Price Book Value Ratio is fairly stable compared to the past year. Ebt Per Ebit is likely to rise to 1.14 in 2024, despite the fact that Free Cash Flow Yield is likely to grow to (0.11).
 2022 2023 2024 (projected)
Interest Debt Per Share0.710.560.59
Revenue Per Share0.210.180.13

Janux Therapeutics fundamentals Correlations

-0.8-0.80.990.980.95-0.81.00.980.80.990.94-1.0-0.950.05-0.69-0.870.36-0.22-0.860.930.320.85-0.86-0.84-0.71
-0.80.96-0.85-0.89-0.751.0-0.8-0.89-0.99-0.79-0.940.80.77-0.020.930.98-0.490.160.98-0.96-0.79-0.990.980.990.96
-0.80.96-0.86-0.89-0.750.96-0.8-0.9-0.93-0.79-0.950.790.77-0.040.960.99-0.260.180.99-0.93-0.69-0.980.990.990.85
0.99-0.85-0.861.00.97-0.850.990.990.850.990.97-0.99-0.970.14-0.75-0.910.38-0.3-0.910.960.380.9-0.91-0.89-0.76
0.98-0.89-0.891.00.95-0.890.981.00.880.980.99-0.98-0.950.1-0.8-0.940.37-0.27-0.940.980.440.93-0.94-0.93-0.79
0.95-0.75-0.750.970.95-0.750.940.930.750.980.89-0.95-1.00.36-0.61-0.820.43-0.52-0.810.890.220.8-0.82-0.79-0.67
-0.81.00.96-0.85-0.89-0.75-0.8-0.89-0.99-0.79-0.940.80.77-0.020.930.98-0.490.160.98-0.96-0.79-0.990.980.990.96
1.0-0.8-0.80.990.980.94-0.80.980.80.990.94-1.0-0.950.04-0.69-0.870.35-0.21-0.860.930.320.85-0.86-0.84-0.71
0.98-0.89-0.90.991.00.93-0.890.980.880.970.99-0.98-0.930.04-0.81-0.950.35-0.21-0.940.980.460.93-0.95-0.93-0.8
0.8-0.99-0.930.850.880.75-0.990.80.880.790.92-0.8-0.770.04-0.89-0.960.58-0.17-0.960.960.80.98-0.96-0.97-0.98
0.99-0.79-0.790.990.980.98-0.790.990.970.790.93-0.99-0.980.17-0.66-0.860.39-0.34-0.850.930.290.84-0.85-0.83-0.7
0.94-0.94-0.950.970.990.89-0.940.940.990.920.93-0.94-0.90.05-0.88-0.980.34-0.21-0.980.990.550.97-0.98-0.97-0.84
-1.00.80.79-0.99-0.98-0.950.8-1.0-0.98-0.8-0.99-0.940.95-0.060.70.87-0.360.240.86-0.93-0.31-0.850.860.840.71
-0.950.770.77-0.97-0.95-1.00.77-0.95-0.93-0.77-0.98-0.90.95-0.360.620.83-0.440.520.83-0.89-0.25-0.810.830.810.68
0.05-0.02-0.040.140.10.36-0.020.040.040.040.170.05-0.06-0.360.11-0.030.32-0.98-0.030.05-0.220.02-0.03-0.03-0.02
-0.690.930.96-0.75-0.8-0.610.93-0.69-0.81-0.89-0.66-0.880.70.620.110.94-0.180.020.94-0.86-0.73-0.940.940.940.83
-0.870.980.99-0.91-0.94-0.820.98-0.87-0.95-0.96-0.86-0.980.870.83-0.030.94-0.360.181.0-0.98-0.68-1.01.01.00.89
0.36-0.49-0.260.380.370.43-0.490.350.350.580.390.34-0.36-0.440.32-0.18-0.36-0.37-0.360.470.520.41-0.36-0.38-0.68
-0.220.160.18-0.3-0.27-0.520.16-0.21-0.21-0.17-0.34-0.210.240.52-0.980.020.18-0.370.18-0.210.16-0.170.180.170.14
-0.860.980.99-0.91-0.94-0.810.98-0.86-0.94-0.96-0.85-0.980.860.83-0.030.941.0-0.360.18-0.98-0.68-1.01.01.00.89
0.93-0.96-0.930.960.980.89-0.960.930.980.960.930.99-0.93-0.890.05-0.86-0.980.47-0.21-0.980.620.98-0.98-0.97-0.9
0.32-0.79-0.690.380.440.22-0.790.320.460.80.290.55-0.31-0.25-0.22-0.73-0.680.520.16-0.680.620.72-0.68-0.71-0.86
0.85-0.99-0.980.90.930.8-0.990.850.930.980.840.97-0.85-0.810.02-0.94-1.00.41-0.17-1.00.980.72-1.0-1.0-0.92
-0.860.980.99-0.91-0.94-0.820.98-0.86-0.95-0.96-0.85-0.980.860.83-0.030.941.0-0.360.181.0-0.98-0.68-1.01.00.9
-0.840.990.99-0.89-0.93-0.790.99-0.84-0.93-0.97-0.83-0.970.840.81-0.030.941.0-0.380.171.0-0.97-0.71-1.01.00.91
-0.710.960.85-0.76-0.79-0.670.96-0.71-0.8-0.98-0.7-0.840.710.68-0.020.830.89-0.680.140.89-0.9-0.86-0.920.90.91
Click cells to compare fundamentals

Janux Therapeutics Account Relationship Matchups

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Janux Stock Analysis

When running Janux Therapeutics' price analysis, check to measure Janux Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Janux Therapeutics is operating at the current time. Most of Janux Therapeutics' value examination focuses on studying past and present price action to predict the probability of Janux Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Janux Therapeutics' price. Additionally, you may evaluate how the addition of Janux Therapeutics to your portfolios can decrease your overall portfolio volatility.